Migraine Trigger-Point / Peripheral Nerve Decompression Surgery | Diagnosis and interpreting the evidence

The assessment usually starts with a careful history and physical examination. You may point with one fingertip to the exact trigger point where pain begins, and gentle pressure there can reproduce pain. For occipital symptoms, no diagnostic imaging is required, although handheld Doppler may help locate vessels near the nerve. A neurologist should first diagnose migraine or tension-type headache using ICHD criteria; candidates usually have frequent severe headaches, while cluster, episodic tension-type and secondary headaches are excluded. Local anesthetic blocks, botulinum toxin and imaging may also be used in the algorithm, and written informed consent is required before surgery. Not every patient qualifies, and selection is strict.

The International Classification of Headache Disorders groups headaches as primary, secondary and cranial neuralgias, with specific symptom criteria for each. Occipital neuralgia is often used loosely for pain from the three occipital nerves, whether the origin is traumatic or nontraumatic, which can confuse diagnosis and surgical planning. Migraine surgery literature focuses on selected patients with peripheral nerve compression at known trigger sites, diagnosed through headache history, hand-held Doppler, local anaesthetic blocks, botulinum toxin and imaging. Neck pain is common in migraine and may be mistaken for cervical spine disease. Careful distinction between traumatic and nontraumatic occipital nerve pain also matters because it can influence whether neurolysis or resection is considered.

Elective decompression is considered only after a headache specialist has diagnosed the condition and excluded secondary causes; surgery is not offered for secondary headaches. Red-flag features include atypical, prolonged or persistent aura; a change in usual pattern; first or worst episode; brainstem symptoms; confusion; motor deficits; side-locked pain; post-trauma headache; fever; immunosuppression; papilledema; or pregnancy. These features raise concern for another cause and should be investigated medically before any elective surgical plan. Imaging can be considered when worrisome features or abnormal examination findings are present, because such patients are more likely to have clinically significant abnormalities. A normal neurological exam and typical migraine pattern make routine neuroimaging unnecessary. Trigger-site mapping supports, but does not replace, diagnosis.

Migraine surgery releases pressure on sensory nerves and nearby vessels around the head. Trigger points are known compression sites; common areas include the forehead, temples, nose or behind the eyes, and back of the head, with less common sites possible. You may have one or several depending on symptoms. Assessment may include a detailed headache history, careful examination and targeted nerve blocks. Each identified point can be released by easing nerve pressure or removing the small nerve branch causing symptoms. The aim is to reduce or eliminate headache frequency, duration and pain. These sites are identified through an algorithmic approach involving thorough headache history, hand-held Doppler, local anesthetic blocks, BTX-A, and imaging studies.

The operation aims to relieve compression of peripheral head and neck nerves at identified trigger sites in selected, appropriately evaluated patients, sometimes by releasing or removing compressing muscle or vessels. Reported complete elimination ranges from 8.3% to 83% across trigger sites, while three randomized trials reported 35% to 57.1%. One auriculotemporal-nerve series reported about 79% success in 57 patients, and one supraorbital series reported about 87% in 98 patients. A systematic review reported 68% to 95% success across 17 trials. Surgery was also reported more successful than stimulators or radiofrequency ablation in one comparison. These figures come from mixed study designs, so they are not a personal prediction for your situation and should be interpreted cautiously.

The Atlas notes that calling it “migraine surgery” can create disagreement because ICHD criteria define primary headaches without an identifiable underlying cause, whereas some frontal headaches may be secondary to supraorbital or supratrochlear nerve entrapment. Plastic-surgery sources describe an algorithm using history, Doppler, blocks, botulinum toxin and imaging to identify compression points, and recommend close collaboration between headache physicians and surgeons. Recent evidence says surgical decompression of extracranial nerves improves headache outcomes for appropriately selected patients, but appropriate patient selection and preoperative diagnosis remain paramount. Thus the difference is partly diagnostic language and patient selection, not simply disagreement about surgery itself.

These numbers are not interchangeable: some measure improvement, others complete elimination, and patients, trigger sites, screening methods and follow-up differ. Success depends on finding all trigger sites; missed or inadequately treated sites and anatomical overlap can cause partial response, and about 18% developed secondary migraine at the same or different sites. Even after surgery, some patients still have pain, light sensitivity or nausea. Complications are usually site-specific and limited in severity, and some patients do not respond despite careful treatment. Reported success also varies by surgical approach, patient selection and individual patient anatomy. No single figure applies to every patient.

The trial included 76 patients whose moderate-to-severe migraine came from a single or predominant trigger site; surgical deactivation of frontal, temporal and occipital trigger points improved headaches compared with sham surgery. Migraine surgery is peripheral nerve decompression: after diagnosis with history, Doppler, blocks, botulinum toxin and imaging, pressure points are released, sometimes by selective muscle resection. Sham improvement may reflect incision and undermining around the trigger point, and failed cases often involved an incorrectly assigned primary trigger site, suggesting more than one trigger point. Chronic refractory cases often need multidisciplinary assessment by neurologists, psychiatrists and surgeons, and it is not a routine first option.

Migraine trigger-point surgery releases pressure on compressed sensory nerves and vessels at identified trigger sites. Because migraine is multifactorial, improvement is reported as complete elimination, significant or moderate improvement, or at least 50% reduction in migraine index, rather than universal cure. The goal is to reduce or eliminate headache frequency, duration and pain, but outcomes vary by patient and trigger site. In one occipital neuralgia series, 81.1% achieved at least 50% overall improvement, including 20.8% complete remission, while 18.8% had no significant improvement; no patient worsened. Even improved patients may still experience photophobia, nausea or other symptoms during attacks. Outcomes are assessed individually, not as a promise of cure.

Complications are relatively limited in severity and are site-specific. Frontal decompression carries a 9% incidence of scalp itching and a 6% incidence of hair loss; temporal decompression carries 53% hollowing, 11% itching, and 5% permanent numbness; occipital decompression carries a 12% risk of intermittent neck stiffness or weakness; rhinogenic decompression carries a 19% risk of nasal dryness, 18% runny nose, 5% sinus infection, and 5% nosebleed needing desmopressin. Intraoperative bleeding was linked to worse outcomes: 8.3% of failed cases had bleeding, while none with success or improvement did. Consent should also cover bleeding, infection, asymmetry, possible additional surgery, delays in healing, unacceptable scarring, and anesthesia risks. No major bleeding requiring return to the operating room has been reported.